Universal Ibogaine Inc. announced a non-brokered private placement offering of up to 30,000,000 common shares at a price of CAD 0.02 per share, for proceeds of up to CAD 600,000 on April 12, 2024. Completion of the Offering is subject to approval by the TSX Venture Exchange. All shares issued under the Offering will be subject to a four-month hold period as required by the rules of the TSXV and Canadian Securities Laws, as well as any required hold periods under US Securities Laws for US resident purchasers.